EuroIntervention PCRonline - Connecting with the community

Patrick W. Serruys

490 articles

First-in-human evaluation of a novel poly-L-lactide based sirolimus-eluting bioresorbable vascular scaffold for the treatment of de novo native coronary artery lesions: MeRes-1 trial

EuroIntervention 2017;13-online publish-ahead-of-print May 2017

Quantitative angiography methods for bifurcation lesions: a consensus statement update from the European Bifurcation Club

EuroIntervention 2017;13:115-123 published online January 2017

Published in Volume 13 Number 1, May 2017

Hierarchical testing of composite endpoints: applying the win ratio to percutaneous coronary intervention versus coronary artery bypass grafting in the SYNTAX trial

EuroIntervention 2017;13:106-114 published online January 2017

Published in Volume 13 Number 1, May 2017

The interaction of de novo and pre-existing aortic regurgitation after TAVI: insights from a new quantitative aortographic technique

EuroIntervention 2017;13:60-68 published online December 2016

Published in Volume 13 Number 1, May 2017

What is it to become an octogenarian 40 years after the first angioplasty?

EuroIntervention 2017;13:11-13

Published in Volume 13 Number 1, May 2017

Five-year follow-up of underexpanded and overexpanded bioresorbable scaffolds: self-correction and impact on shear stress

EuroIntervention 2017;12:2158-2159 published online ahead of print March 2017

Published in Volume 12 Number 17, April 2017

First-in-man six-month results of a surface-modified coronary stent system in native coronary stenosis

EuroIntervention 2017;12:2018-2027 published online December 2016

Published in Volume 12 Number 17, April 2017

Dmax for sizing, PSP-1, PSP-2, PSP-3 or OCT guidance: interventionalist’s jargon or indispensable implantation techniques for short- and long-term outcomes of Absorb BRS?

EuroIntervention 2017;12:2047-2056 published online ahead of print March 2017

Published in Volume 12 Number 17, April 2017

Change in lumen eccentricity and asymmetry after treatment with Absorb bioresorbable vascular scaffolds in the ABSORB cohort B trial: a five-year serial optical coherence tomography imaging study

EuroIntervention 2017;12:e2244-e2252 published online December 2016 published online e-edition April 2017

Published in Volume 12 Number 18, April 2017

Pressure-mediated versus pharmacologic treatment of radial artery spasm during cardiac catheterisation: a randomised pilot study

EuroIntervention 2017;12:e2212-e2218 published online December 2016 published online e-edition April 2017

Published in Volume 12 Number 18, April 2017

Does geographical variability influence 5-year MACCE rates in the multicenter SYNTAX revascularization trial?

EuroIntervention 2017; just accepted article published in March 2017

Non-invasive Heart Team assessment of multivessel coronary disease with coronary computed tomography angiography based on SYNTAX score II treatment recommendations: design and rationale of the randomised SYNTAX III Revolution trial

EuroIntervention 2017;12:2001-2008 published online December 2016

Published in Volume 12 Number 16, March 2017

Is quantitative coronary angiography reliable in assessing the late lumen loss of the everolimus eluting bioresorbable polylactide scaffold in comparison with the cobalt chromium metallic stent?

EuroIntervention 2017; just accepted article published in March 2017

Impact of stent overlapping on long-term clinical outcomes in patients with ST-segment elevation myocardial infarction: insights from the 5-year follow-up of the EXAMINATION trial

EuroIntervention 2017; just accepted article published in February 2017

Everolimus Eluting Bioresorbable Vascular Scaffold for Treatment of Complex Chronic Total Occlusions

EuroIntervention 2017; just accepted article published in February 2017

Instantaneous wave-free ratio to guide coronary revascularization: physiological framework, validation and differences with fractional flow reserve

EuroIntervention 2017; just accepted article published in February 2017

Possible mechanical causes of scaffold thrombosis: insights from case reports with intracoronary imaging

EuroIntervention 2017;12:1747-1756 published online October 2016

Published in Volume 12 Number 14, February 2017

Impact of lesion calcification on angiographic outcomes after Absorb everolimus-eluting bioresorbable vascular scaffold implantation: an observation from the ABSORB Japan trial

EuroIntervention 2017;12:1738-1746 published online November 2016

Published in Volume 12 Number 14, February 2017

Comparison of clinical outcomes after multivessel versus single-vessel stenting with the zotarolimus-eluting stent in the RESOLUTE Global Clinical Trial Program

EuroIntervention 2017;12:1605-1613 published online October 2016

Published in Volume 12 Number 13, January 2017

Selective use of contemporary drug-eluting stents in primary angioplasty for ST-elevation myocardial infarction: pooled analysis of COMFORTABLE AMI and EXAMINATION

EuroIntervention 2017;12:1577-1586 published online October 2016

Published in Volume 12 Number 13, January 2017

When first is first: first in man…or pioneer?

EuroIntervention 2017;12:1559-1560

Published in Volume 12 Number 13, January 2017

Comparative analysis method of permanent metallic stents (XIENCE) and bioresorbable poly-L-lactic (PLLA) scaffolds (Absorb) on optical coherence tomography at baseline and follow-up

EuroIntervention 2016;12:1498-1509 published online ahead of print October 2015

Published in Volume 12 Number 12, December 2016

Regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM® stent: the randomised, multicentre, open-label, controlled POLBOS II trial

EuroIntervention 2016;12:e1404-e1412 published online ahead of print November 2015 published online e-edition December 2016

Published in Volume 12 Number 11, December 2016

DESyne novolimus-eluting coronary stent is superior to Endeavor zotarolimus-eluting coronary stent at five-year follow-up: final results of the multicentre EXCELLA II randomised controlled trial

EuroIntervention 2016;12:e1336-e1342 published online ahead of print October 2015 published online e-edition December 2016

Published in Volume 12 Number 11, December 2016

Preclinical assessment of the endothelial shear stress in porcine-based models following implantation of two different bioresorbable scaffolds: effect of scaffold design on the local haemodynamic micro-environment

EuroIntervention 2016;12:1296 published online ahead of print May 2016

Published in Volume 12 Number 10, November 2016

One-year clinical outcomes of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a propensity score comparison of patients enrolled in the ABSORB EXTEND and SPIRIT trials

EuroIntervention 2016;12:1255-1262

Published in Volume 12 Number 10, November 2016

Long-term effectiveness and safety of the sirolimus-eluting BiOSS LIM® dedicated bifurcation stent in the treatment of distal left main stenosis: an international registry

EuroIntervention 2016;12:1246-1254 published online ahead of print October 2015

Published in Volume 12 Number 10, November 2016

Long-term ticagrelor monotherapy versus standard dual antiplatelet therapy followed by aspirin monotherapy in patients undergoing biolimus-eluting stent implantation: rationale and design of the GLOBAL LEADERS trial

EuroIntervention 2016;12:1239-1245 published online ahead of print November 2015

Published in Volume 12 Number 10, November 2016

Outcomes of stenting extra-small (≤2.25 mm) vessels using the Resolute zotarolimus-eluting stent (R-ZES)

EuroIntervention 2016;12:1215-1221

Published in Volume 12 Number 10, November 2016

Long-term outcomes after Resolute zotarolimus-eluting stent implantation in patients with ST-segment elevation acute myocardial infarction: insights from the RESOLUTE All Comers Trial and the RESOLUTE Global Clinical Trial Program

EuroIntervention 2016;12:1207-1214

Published in Volume 12 Number 10, November 2016

Quantification by optical coherence tomography imaging of the ablation volume obtained with the Orbital Atherectomy System in calcified coronary lesions

EuroIntervention 2016;12:1126-1134

Published in Volume 12 Number 9, October 2016

Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trial

EuroIntervention 2016;12:1102-1107 published online ahead of print August 2016

Published in Volume 12 Number 9, October 2016

Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial

EuroIntervention 2016;12:1090-1101 published online ahead of print September 2016

Published in Volume 12 Number 9, October 2016

Very late scaffold thrombosis after bioresorbable scaffold implantation: an unexpected new enemy on the horizon… or just a false alarm?

EuroIntervention 2016;12:1077-1079

Published in Volume 12 Number 9, October 2016

Four-year experience with the CoreValve transcatheter heart valve

EuroIntervention 2016;12:e1039-e1046 published online ahead of print October 2015 published online e-edition October 2016

Published in Volume 12 Number 8, October 2016

Is quantitative coronary angiography reliable in assessing the lumen gain after treatment with the everolimus-eluting bioresorbable polylactide scaffold?

EuroIntervention 2016;12:e998-e1008 published online e-edition October 2016

Published in Volume 12 Number 8, October 2016

Variability in the measurement of minimum fibrous cap thickness and reproducibility of fibroatheroma classification by optical coherence tomography using manual versus semi-automatic assessment

EuroIntervention 2016;12:e987-e997 published online e-edition October 2016

Published in Volume 12 Number 8, October 2016

Clinical outcomes of “complete, partially complete, and incomplete” revascularisation at five-year follow-up after percutaneous intervention of unprotected left main coronary artery disease with drug-eluting stents

EuroIntervention 2016;12:e957-e963 published online ahead of print December 2015 published online e-edition October 2016

Published in Volume 12 Number 8, October 2016

Paul Cummins, Managing Editor: farewell and many thanks!

EuroIntervention 2016;12:e933-e934 published online e-edition October 2016

Published in Volume 12 Number 8, October 2016

Patient selection for TAVI in 2016: should we break through the low-risk barrier?

EuroIntervention 2016;12:Y46-Y50

Published in Volume 12 Supplement Y, September 2016

Design and rationale for a randomised comparison of everolimus-eluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease: the EXCEL trial

EuroIntervention 2016;12:861-872

Published in Volume 12 Number 7, September 2016

Bioresorbable vascular scaffold radial expansion and conformation compared to a metallic platform: insights from in vitro expansion in a coronary artery lesion model

EuroIntervention 2016;12:834-844

Published in Volume 12 Number 7, September 2016

Periprocedural myocardial infarction in stent trials: how universal is the third universal definition?

EuroIntervention 2016;12:813-817

Published in Volume 12 Number 7, September 2016

Five-year haemodynamic outcomes of the first-generation SAPIEN balloon-expandable transcatheter heart valve

Published in Volume 12 Number 6, August 2016

Integrated Biomarker and Imaging Study 3 (IBIS-3) to assess the ability of rosuvastatin to decrease necrotic core in coronary arteries

Published in Volume 12 Number 6, August 2016

The Heart Team – perpetually mutating

EuroIntervention 2016;12:693

Published in Volume 12 Number 6, August 2016

Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for acute coronary syndrome from the DELTA registry: a multicentre registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment

EuroIntervention 2016;12:e623-e631 published online e-edition August 2016

Published in Volume 12 Number 5, August 2016

Direct implantation of rapamycin-eluting stents with bioresorbable drug carrier technology utilising the Svelte coronary stent-on-a-wire: the DIRECT II study

EuroIntervention 2016;12:e615-e622 published online e-edition August 2016

Published in Volume 12 Number 5, August 2016

Evaluation of vascular healing of polymer-free sirolimus-eluting stents in native coronary artery stenosis: a serial follow-up at three and six months with optical coherence tomography imaging

EuroIntervention 2016;12:e574-e583 published online e-edition August 2016

Published in Volume 12 Number 5, August 2016

Meta-analysis: don’t do what I did

EuroIntervention 2016;12:e535 published online e-edition August 2016

Published in Volume 12 Number 5, August 2016

Arterial healing following primary PCI using the Absorb everolimus-eluting bioresorbable vascular scaffold (Absorb BVS) versus the durable polymer everolimus-eluting metallic stent (XIENCE) in patients with acute ST-elevation myocardial infarction: rationale and design of the randomised TROFI II study

EuroIntervention 2016;12:482-489 published online ahead of print August 2015

Published in Volume 12 Number 4, July 2016

Incidence and predictors of unplanned non-target lesion revascularisation up to three years after drug-eluting stent implantation: insights from a pooled analysis of the RESOLUTE Global Clinical Trial Program

EuroIntervention 2016;12:465-472 published online ahead of print July 2015

Published in Volume 12 Number 4, July 2016

The Journal Citation Reports® Impact Factor: annual results 2016

EuroIntervention 2016;12:415-416

Published in Volume 12 Number 4, July 2016

VARC endpoint definition compliance rates in contemporary transcatheter aortic valve implantation studies

EuroIntervention 2016;12:375-380

Published in Volume 12 Number 3, June 2016

High-sensitivity C-reactive protein predicts 10-year cardiovascular outcome after percutaneous coronary intervention

EuroIntervention 2016;12:345-351 published online ahead of print July 2015

Published in Volume 12 Number 3, June 2016

EuroIntervention at 100 issues

EuroIntervention 2016;12:295

Published in Volume 12 Number 3, June 2016

Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease

EuroIntervention 2016;12:e224-e234 published online e-edition June 2016

Published in Volume 12 Number 2, June 2016

Comparison of clinical outcomes between bioresorbable vascular stents versus conventional drug-eluting and metallic stents: a systematic review and meta-analysis

EuroIntervention 2016;12:e175-e189 published online e-edition June 2016

Published in Volume 12 Number 2, June 2016

Looking into the publishing orbuculum: the year 2020

EuroIntervention 2016;12:129

Published in Volume 12 Number 2, June 2016

Translational interventional cardiology: a new editorial priority for EuroIntervention

EuroIntervention 2016;12:11-13

Published in Volume 12 Number 1, May 2016

Becoming future ready: preparing today for the wants of tomorrow

EuroIntervention 2016;12:9

Published in Volume 12 Number 1, May 2016

Significance of prior percutaneous revascularisation in patients with acute coronary syndromes: insights from the prospective PROSPECT registry

EuroIntervention 2016;11:1468-1474

Published in Volume 11 Number 13, April 2016

Bioresorbable scaffolds for the treatment of in-stent restenosis: an alternative to double metal layers?

EuroIntervention 2016;11:1451-1453

Published in Volume 11 Number 13, April 2016

DAPT: a historical accident in the pharmacological treatment of post-percutaneous coronary intervention

EuroIntervention 2016;11:1449-1450

Published in Volume 11 Number 13, April 2016

Forward and back aspiration during ST-elevation myocardial infarction: a feasibility study

EuroIntervention 2016;11:e1639-e1648 published online e-edition April 2016

Published in Volume 11 Number 14, April 2016

Observations from the recent FDA Circulatory System Devices Panel meeting on bioresorbable vascular scaffolds

EuroIntervention 2016;11:e1569-e1570 published online e-edition April 2016

Published in Volume 11 Number 14, April 2016

Video densitometric assessment of aortic regurgitation after transcatheter aortic valve implantation: results from the Brazilian TAVI registry

EuroIntervention 2016;11:1409-1418

Published in Volume 11 Number 12, March 2016

The Mitral Valve Meeting in Zurich – a world upside down

EuroIntervention 2016;11:1329

Published in Volume 11 Number 12, March 2016

Calling a “cat a cat”: has the time come to return to “valvular disease” from “structural heart”?

EuroIntervention 2016;11:1087

Published in Volume 11 Number 10, February 2016

Cherry picking into the digital age!

EuroIntervention 2016;11:e1207-e1208 published online e-edition February 2016

Published in Volume 11 Number 11, February 2016

Long-term invasive follow-up of the everolimus-eluting bioresorbable vascular scaffold: five-year results of multiple invasive imaging modalities

EuroIntervention 2016;11:996-1003 published online ahead of print October 2014

Published in Volume 11 Number 9, January 2016

TAVI adoption in Germany: onwards and upwards

EuroIntervention 2016;11:968-970

Published in Volume 11 Number 9, January 2016

Listen, understand and act - developing modern scientific engagement

EuroIntervention 2015;11:967

Published in Volume 11 Number 9, January 2016

Incidence and potential mechanism of resolved, persistent and newly acquired malapposition three days after implantation of self-expanding or balloon-expandable stents in a STEMI population: insights from optical coherence tomography in the APPOSITION II study

EuroIntervention 2015;11:885-894 published online ahead of print November 2015

Published in Volume 11 Number 8, December 2015

A vote taking place on 2 December 2015 (EUCOMED) that will definitely influence our profession and continuing medical education

EuroIntervention 2015;11:847-849

Published in Volume 11 Number 8, December 2015

Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography data

EuroIntervention 2015;11:746-756 published online ahead of print October 2014

Published in Volume 11 Number 7, November 2015

Peripheral vascular disease: shaping a new panvascular interventional approach

EuroIntervention 2015;11:729

Published in Volume 11 Number 7, November 2015

Clinical results with the Resolute zotarolimus-eluting stent in total coronary occlusions

EuroIntervention 2015;11:650-657 published online ahead of print July 2014

Published in Volume 11 Number 6, October 2015

Reasonable incomplete revascularisation after percutaneous coronary intervention: the SYNTAX Revascularisation Index

EuroIntervention 2015;11:634-642 published online ahead of print October 2014

Published in Volume 11 Number 6, October 2015

The triad of residual ischaemia, plaque burden, and plaque vulnerability: a known known?…a known unknown?...or an unknown unknown?

EuroIntervention 2015;11:611-619

Published in Volume 11 Number 6, October 2015

The next step for mitral valve treatment: moving to early percutaneous intervention to prevent irreversible damage

EuroIntervention 2015;11:609

Published in Volume 11 Number 6, October 2015

The era of a new generation of interventionalists: a hybrid of a surgeon and an interventionalist?

EuroIntervention 2015;11:

Published in Volume 11 Number 5, September 2015

Reversal of flow between serial bifurcation lesions: insights from computational fluid dynamic analysis in a population-based phantom model

EuroIntervention 2015;11:e1-e3 published online e-article September 2015

Published in Volume 11 Number 5, September 2015

Impact of the orbital atherectomy system on a coronary calcified lesion: quantitative analysis by light attenuation in optical coherence tomography

EuroIntervention 2015;11:e1 published online e-article September 2015

Published in Volume 11 Number 5, September 2015

Five-year clinical outcome of the Nobori drug-eluting coronary stent system in the treatment of patients with coronary artery disease: final results of the NOBORI 1 trial

EuroIntervention 2015;11:549-554 published online ahead of print December 2014

Published in Volume 11 Number 5, September 2015

Differences in coronary risk factors, procedural characteristics, mortality and stent thrombosis between two all-comers percutaneous coronary intervention registries from Europe and Japan: a patient-level data analysis of the Bern-Rotterdam and j-Cypher registries

EuroIntervention 2015;11:533-540 published online ahead of print June 2014

Published in Volume 11 Number 5, September 2015

The Sino Medical AccuFit transcatheter mitral valve implantation system

EuroIntervention 2015;11:W84-W85

Published in Volume 11 Supplement W, September 2015

Rotational angiography with motion compensation: first-in-man use for the 3D evaluation of transcatheter valve prostheses

EuroIntervention 2015;11:442-449 published online ahead of print June 2014

Published in Volume 11 Number 4, August 2015

Anatomically correct three-dimensional coronary artery reconstruction using frequency domain optical coherence tomographic and angiographic data: head-to-head comparison with intravascular ultrasound for endothelial shear stress assessment in humans

EuroIntervention 2015;11:407-415 published online ahead of print June 2014

Published in Volume 11 Number 4, August 2015

This is London calling: a few recollections on the path to the 2015 ESC congress

EuroIntervention 2015;11:369

Published in Volume 11 Number 4, August 2015

A call for a new codified approach for experimentation in humans

EuroIntervention 2015;11:249

Published in Volume 11 Number 3, July 2015

Clinical outcome of patients with stable ischaemic heart disease as compared to those with acute coronary syndromes after percutaneous coronary intervention

EuroIntervention 2015;11:171-179

Published in Volume 11 Number 2, June 2015

Impact of post-dilation on the acute and one-year clinical outcomes of a large cohort of patients treated solely with the Absorb Bioresorbable Vascular Scaffold

EuroIntervention 2015;11:141-148 published online ahead of print May 2015

Published in Volume 11 Number 2, June 2015

Leaving EuroPCR’s Maillot port dedicated to percutaneous mitral valve replacement: setting our nautical course by the stars!

EuroIntervention 2015;11:129

Published in Volume 11 Number 2, June 2015

Foundations for tomorrow: EuroIntervention at ten years

EuroIntervention 2015;11:13

Published in Volume 11 Number 1, May 2015

The future of BRS in bifurcations

EuroIntervention 2015;11:V188-V192

Published in Volume 11 Supplement V, May 2015

Technology limitations of BRS in bifurcations

EuroIntervention 2015;11:V155-V158

Published in Volume 11 Supplement V, May 2015

The Tryton Side Branch Stent

EuroIntervention 2015;11:V145-V146

Published in Volume 11 Supplement V, May 2015

Dedicated stents for distal left main stenting

EuroIntervention 2015;11:V129-V134

Published in Volume 11 Supplement V, May 2015

The EXCEL and NOBLE trials: similarities, contrasts and future perspectives for left main revascularisation

EuroIntervention 2015;11:V115-V119

Published in Volume 11 Supplement V, May 2015

New implication of three-dimensional optical coherence tomography in optimising bifurcation PCI

EuroIntervention 2015;11:V71-V74

Published in Volume 11 Supplement V, May 2015

The need for dedicated bifurcation quantitative coronary angiography (QCA) software algorithms to evaluate bifurcation lesions

EuroIntervention 2015;11:V44-V49

Published in Volume 11 Supplement V, May 2015

The treatment of coronary bifurcations: a true art form

EuroIntervention 2015;11:V7

Published in Volume 11 Supplement V, May 2015

Long-term outcomes of biodegradable versus durable polymer drug-eluting stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of individual patient data from three randomised trials

EuroIntervention 2015;10:1425-1431 published online ahead of print February 2014

Published in Volume 10 Number 12, April 2015

Five-year outcomes of staged percutaneous coronary intervention in the SYNTAX study

EuroIntervention 2015;10:1402-1408

Published in Volume 10 Number 12, April 2015

The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled

EuroIntervention 2015;10:1396-1401 published online ahead of print April 2014

Published in Volume 10 Number 12, April 2015

Sensors, wearables and devices in the e-age: tomorrow's world today

EuroIntervention 2015;10:1373

Published in Volume 10 Number 12, April 2015

First report on free expansion simulations of a dedicated bifurcation stent mounted on a stepped balloon

EuroIntervention 2015;10:e1-e3 published online e-article March 2015

Published in Volume 10 Number 11, March 2015

Circumferential distribution of the neointima at six-month and two-year follow-up after a bioresorbable vascular scaffold implantation: a substudy of the ABSORB Cohort B Clinical Trial

EuroIntervention 2015;10:1299-1306 published online ahead of print April 2014

Published in Volume 10 Number 11, March 2015

Early (before 6 months), late (6-12 months) and very late (after 12 months) angiographic scaffold restenosis in the ABSORB Cohort B trial

EuroIntervention 2015;10:1288-1298 published online ahead of print February 2014

Published in Volume 10 Number 11, March 2015

Assessing percutaneous intervention: re-appraising the significance of residual angina

EuroIntervention 2015;10:1253

Published in Volume 10 Number 11, March 2015

Renal denervation reloaded: where to go from here?

EuroIntervention 2015;10:1135-1137

Published in Volume 10 Number 10, February 2015

Evolutions and reflections on returning from AsiaPCR/SingLIVE 2015

EuroIntervention 2015;10:1133

Published in Volume 10 Number 10, February 2015

Short-term effects of Nano+™ polymer-free sirolimus-eluting stents on native coronary vessels: an optical coherence tomography imaging study

AsiaIntervention 2015;1:57-70

Published in Asiaintervention Volume 1 Issue 1, January 2015

AsiaIntervention – “you cannot open a book without learning something”

AsiaIntervention 2015;1:9

Published in Asiaintervention Volume 1 Issue 1, January 2015

Positioning consensus for guidance

EuroIntervention 2015;10:1013-1014

Published in Volume 10 Number 9, January 2015

Relation of genetic profile and novel circulating biomarkers with coronary plaque phenotype as determined by intravascular ultrasound: rationale and design of the ATHEROREMO-IVUS study

EuroIntervention 2014;10:953-960 published online ahead of print August 2013

Published in Volume 10 Number 8, December 2014

3D optical coherence tomography: new insights into the process of optimal rewiring of side branches during bifurcational stenting

EuroIntervention 2014;10:907-915 published online ahead of print February 2014

Published in Volume 10 Number 8, December 2014

The Dual Antiplatelet Therapy study at the American Heart Association meeting: an issue that concerns all of us. Future changes in the paradigm or a look into the past?

EuroIntervention 2014;10:893-895 published online ahead of print November 2014

Published in Volume 10 Number 8, December 2014

Construction and validation of a plaque discrimination score from the anatomical and histological differences in coronary atherosclerosis: the Liverpool IVUS-V-HEART (Intra Vascular UltraSound-Virtual-Histology Evaluation of Atherosclerosis Requiring Treatment) study

EuroIntervention 2014;10:815-823 published online ahead of print January 2014

Published in Volume 10 Number 7, November 2014

The acute ischaemic stroke team: one great step forward

EuroIntervention 2014;10:773

Published in Volume 10 Number 7, November 2014

Comparison of acute gain and late lumen loss after PCI with bioresorbable vascular scaffolds versus everolimus-eluting stents: an exploratory observational study prior to a randomised trial

EuroIntervention 2014;10:672-680 published online ahead of print January 2014

Published in Volume 10 Number 6, October 2014

The annual ESC Congress: a fixed point in a changing age

EuroIntervention 2014;10:653

Published in Volume 10 Number 6, October 2014

Fast virtual functional assessment of intermediate coronary lesions using routine angiographic data and blood flow simulation in humans: comparison with pressure wire – fractional flow reserve

EuroIntervention 2014;10:574-583 published online ahead of print July 2014

Published in Volume 10 Number 5, September 2014

Impact Factor 2014: hoping this will be more the rule than the exception

EuroIntervention 2014;10:533

Published in Volume 10 Number 5, September 2014

Serial intravascular ultrasound observations from the Tryton first-in-man study

EuroIntervention 2014;10:475-483

Published in Volume 10 Number 4, August 2014

Lessons learned from acute and late scaffold failures in the ABSORB EXTEND trial

EuroIntervention 2014;10:449-457 published online ahead of print January 2014

Published in Volume 10 Number 4, August 2014

Innovations: resetting our thinking to solve problems

EuroIntervention 2014;10:413

Published in Volume 10 Number 4, August 2014

Hybrid intravascular imaging: the key for a holistic evaluation of plaque pathology

EuroIntervention 2014;10:296-298

Published in Volume 10 Number 3, July 2014

Imaging for interventional cardiologists: the sine qua non condition

EuroIntervention 2014;10:293

Published in Volume 10 Number 3, July 2014

Procedural and clinical outcomes of the Absorb everolimus-eluting bioresorbable vascular scaffold: one-month results of the Bioresorbable vascular Scaffold Evaluated At Rotterdam Cardiology Hospitals (B-SEARCH)

EuroIntervention 2014;10:236-240 published online ahead of print September 2013

Published in Volume 10 Number 2, June 2014

PCR Innovation Day: connecting the innovation dots

EuroIntervention 2014;10:173

Published in Volume 10 Number 2, June 2014

Flow disturbances in stent-related coronary evaginations: a computational fluid-dynamic simulation study

EuroIntervention 2014;10:113-123 published online ahead of print November 2013

Published in Volume 10 Number 1, May 2014

“Coming together is a beginning. Keeping together is progress. Working together is success.”

EuroIntervention 2014;10:11

Published in Volume 10 Number 1, May 2014

Long-term comparison of everolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for percutaneous coronary intervention of saphenous vein grafts

EuroIntervention 2014;9:1432-1440 published online ahead of print August 2013

Published in Volume 9 Number 12, April 2014

Innovation: “It’s about the people you have!”

EuroIntervention 2014;9:1369

Published in Volume 9 Number 12, April 2014

Transcatheter aortic valve replacement and vascular complications definitions

EuroIntervention 2014;9:1317-1322

Published in Volume 9 Number 11, March 2014

Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months

EuroIntervention 2014;9:1271-1284 published online ahead of print December 2013

Published in Volume 9 Number 11, March 2014

Is evidence actually evidence?

EuroIntervention 2014;9:1249

Published in Volume 9 Number 11, March 2014

The scientific power of a “sham” arm?

EuroIntervention 2014;9:1129-1131

Published in Volume 9 Number 10, February 2014

Natural history of optical coherence tomography-detected non-flow-limiting edge dissections following drug-eluting stent implantation

EuroIntervention 2014;9:1085-1094 published online ahead of print August 2013

Published in Volume 9 Number 9, January 2014

Review and recommendations on the current practice of meta-analyses: a guide to appraise the evidence

EuroIntervention 2014;9:1013-1020

Published in Volume 9 Number 9, January 2014

Innovations, inventions and improvements

EuroIntervention 2014;9:1011

Published in Volume 9 Number 9, January 2014

The coronary artery bypass graft SYNTAX Score: final five-year outcomes from the SYNTAX-LE MANS left main angiographic substudy

EuroIntervention 2013;9:1009-1010 published online ahead of print April 2013

Published in Volume 9 Number 8, December 2013

In vivo assessment of the relationship between shear stress and necrotic core in early and advanced coronary artery disease

EuroIntervention 2013;9:989-995 published online ahead of print March 2013

Published in Volume 9 Number 8, December 2013

Quantification of scientific output in cardiovascular medicine: a perspective based on global data

EuroIntervention 2013;9:975-978 published online ahead of print August 2013

Published in Volume 9 Number 8, December 2013

Single-vessel or multivessel PCI in patients with multivessel disease presenting with non-ST-elevation acute coronary syndromes

EuroIntervention 2013;9:916-922

Published in Volume 9 Number 8, December 2013

Reflections on STEMI

EuroIntervention 2013;9:893

Published in Volume 9 Number 8, December 2013

Revisiting: “Comparison of intravascular ultrasound versus angiography-guided drug-eluting stent implantation: a meta-analysis of one randomised trial and ten observational studies involving 19,619 patients”

EuroIntervention 2013;9:891-892 published online ahead of print April 2013

Published in Volume 9 Number 7, November 2013

In vivo assessment of the three-dimensional haemodynamic micro-environment following drug-eluting bioresorbable vascular scaffold implantation in a human coronary artery: fusion of frequency domain optical coherence tomography and angiography

EuroIntervention 2013;9:890 published online ahead of print July 2013

Published in Volume 9 Number 7, November 2013

Coronary artery bypass graft versus percutaneous coronary intervention with drug-eluting stent implantation for diabetic patients with unprotected left main coronary artery disease: the D-DELTA registry

EuroIntervention 2013;9:803-808

Published in Volume 9 Number 7, November 2013

Asia rising

EuroIntervention 2013;9:775

Published in Volume 9 Number 7, November 2013

The edge vascular response following implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold and the XIENCE V metallic everolimus-eluting stent. First serial follow-up assessment at six months and two years: insights from the first-in-man ABSORB Cohort B and SPIRIT II trials

EuroIntervention 2013;9:709-720 published online ahead of print April 2013

Published in Volume 9 Number 6, October 2013

The European Heart Journal and EuroIntervention: information and education in interventional cardiology

EuroIntervention 2013;9:669-680

Published in Volume 9 Number 6, October 2013

ESC Journals working together

EuroIntervention 2013;9:655

Published in Volume 9 Number 6, October 2013

A sense of “déjà vu”?

EuroIntervention 2013;9:535

Published in Volume 9 Number 5, September 2013

Transcatheter aortic valve update 2013

EuroIntervention 2013;9:S84-S90

Published in Volume 9 Supplement S, September 2013

Observations from the CREDO-Kyoto three-vessel disease registry: can one adjust for the unadjustable?

EuroIntervention 2013;9:419-421

Published in Volume 9 Number 4, August 2013

TAVI in Europe – that was then and this is now

EuroIntervention 2013;9:415-417

Published in Volume 9 Number 4, August 2013

Health-related quality of life in the elderly three years after percutaneous coronary intervention

EuroIntervention 2013;9:373-381

Published in Volume 9 Number 3, July 2013

The Journal Citation Reports® Impact Factor: annual results 2012

EuroIntervention 2013;9:294-295

Published in Volume 9 Number 3, July 2013

Cost-effectiveness: the ménage à trois having a ratio with one denominator and one numerator

EuroIntervention 2013;9:173

Published in Volume 9 Number 2, June 2013

Emerging technologies: polymer-free phospholipid encapsulated sirolimus nanocarriers for the controlled release of drug from a stent-plus-balloon or a stand-alone balloon catheter

EuroIntervention 2013;9:148-156

Published in Volume 9 Number 1, May 2013

Clinical and angiographic outcomes following first-in-man implantation of a novel thin-strut low-profile fixed-wire stent: the Svelte Coronary Stent Integrated Delivery System first-in-man trial

EuroIntervention 2013;9:125-134

Published in Volume 9 Number 1, May 2013

The great iFR vs. FFR debate: why sometimes “the wait and see approach” is the best tactic as the best pragmatic solution will always emerge and become established

EuroIntervention 2013;9:11-13

Published in Volume 9 Number 1, May 2013

Advanced three-dimensional quantitative coronary angiographic assessment of bifurcation lesions: methodology and phantom validation

EuroIntervention 2013;8:1451-1460

Published in Volume 8 Number 12, April 2013

Travelling around the world with interventional cardiology

EuroIntervention 2013;8:1347

Published in Volume 8 Number 12, April 2013

The CABG SYNTAX Score - an angiographic tool to grade the complexity of coronary disease following coronary artery bypass graft surgery: from the SYNTAX Left Main Angiographic (SYNTAX-LE MANS) substudy

EuroIntervention 2013;8:1277-1285 published online ahead of print August 2012

Published in Volume 8 Number 11, March 2013

Acute procedural and six-month clinical outcome in patients treated with a dedicated bifurcation stent for left main stem disease: the TRYTON LM multicentre registry

EuroIntervention 2013;8:1259-1269

Published in Volume 8 Number 11, March 2013

On EEPs and e-blasts, cluster publishing, consensus and interventional cardiology

EuroIntervention 2013;8:1229

Published in Volume 8 Number 11, March 2013

Five-year follow-up of the ABSORB bioresorbable everolimus-eluting vascular scaffold system: multimodality imaging assessment

EuroIntervention 2013;8:1226-1227 published online ahead of print September 2012

Published in Volume 8 Number 10, February 2013

Full circle: from thrombolysis to PCI post-thrombolysis, to thrombolysis with PCI, to PCI alone to thrombectomy alone, to nanothrombolysis

EuroIntervention 2013;8:1112-1113

Published in Volume 8 Number 10, February 2013

Five-year long-term clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery disease: the SPIRIT II trial

EuroIntervention 2013;8:1047-1051

Published in Volume 8 Number 9, January 2013

The authors’ challenge

EuroIntervention 2013;8:995

Published in Volume 8 Number 9, January 2013

Plaque sealing and passivation with a mechanical self-expanding low outward force nitinol vShield device for the treatment of IVUS and OCT-derived thin cap fibroatheromas (TCFAs) in native coronary arteries: report of the pilot study vShield Evaluated at Cardiac hospital in Rotterdam for Investigation and Treatment of TCFA (SECRITT)

EuroIntervention 2012;8:945-954

Published in Volume 8 Number 8, December 2012

Age- and gender-related changes in plaque composition in patients with acute coronary syndrome: the PROSPECT study

EuroIntervention 2012;8:929-938

Published in Volume 8 Number 8, December 2012

Short- and long-term outcomes in octogenarians undergoing percutaneous coronary intervention with stenting

EuroIntervention 2012;8:920-928

Published in Volume 8 Number 8, December 2012

Peer reviewers – indispensable elements in the publishing universe

EuroIntervention 2012;8:879-881

Published in Volume 8 Number 8, December 2012

Comparison of intravascular ultrasound versus angiography-guided drug-eluting stent implantation: a meta-analysis of one randomised trial and ten observational studies involving 19,619 patients

EuroIntervention 2012;8:855-865

Published in Volume 8 Number 7, November 2012

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document

EuroIntervention 2012;8:782-795

Published in Volume 8 Number 7, November 2012

A new international presence in interventional cardiology

EuroIntervention 2012;8:763

Published in Volume 8 Number 7, November 2012

What is the “What”: reflections on language after PCR London Valves

EuroIntervention 2012;8:645-647

Published in Volume 8 Number 6, October 2012

Transcatheter aortic valve implantation: new developments and upcoming clinical trials

EuroIntervention 2012;8:617-627 published online ahead of print May 2012

Published in Volume 8 Number 5, September 2012

Stent thrombosis: insights on outcomes, predictors and impact of dual antiplatelet therapy interruption from the SPIRIT II, SPIRIT III, SPIRIT IV and COMPARE trials

EuroIntervention 2012;8:599-606

Published in Volume 8 Number 5, September 2012

The “Big Brother”

EuroIntervention 2012;8:529

Published in Volume 8 Number 5, September 2012

Building on the shoulders of giants: the Valve Academic Research Consortium (VARC) initiative towards a global framework to guide valvular heart disease trials

EuroIntervention 2012;8:Q12-Q14

Published in Volume 8 Supplement Q, September 2012

Non-invasive fractional flow reserve: scientific basis, methods and perspectives

EuroIntervention 2012;8:511-519 published online ahead of print May 2012

Published in Volume 8 Number 4, August 2012

Lettres de noblesse: the three milestones

EuroIntervention 2012;8:411

Published in Volume 8 Number 4, August 2012

Angiographic and histological results following implantation of a novel stent-on-a-wire in the animal model

EuroIntervention 2012;8:390-399 published online ahead of print February 2012

Published in Volume 8 Number 3, July 2012

Head to head comparison of optical coherence tomography, intravascular ultrasound echogenicity and virtual histology for the detection of changes in polymeric struts over time: insights from the ABSORB trial

EuroIntervention 2012;8:352-358 published online ahead of print November 2011

Published in Volume 8 Number 3, July 2012

Far from the turmoil, a summer with EuroIntervention

EuroIntervention 2012;8:293

Published in Volume 8 Number 3, July 2012

The SURTAVI model: proposal for a pragmatic risk stratification for patients with severe aortic stenosis

EuroIntervention 2012;8:258-266 publish online ahead of print March 2012

Published in Volume 8 Number 2, June 2012

The ability of high dose rosuvastatin to improve plaque composition in non-intervened coronary arteries: rationale and design of the Integrated Biomarker and Imaging Study-3 (IBIS-3)

EuroIntervention 2012;8:235-241

Published in Volume 8 Number 2, June 2012

Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-study

EuroIntervention 2012;8:214-224

Published in Volume 8 Number 2, June 2012

Are they really wolves in sheeps’ clothing?

EuroIntervention 2012;8:173-175

Published in Volume 8 Number 2, June 2012

Offline fusion of co-registered intravascular ultrasound and frequency domain optical coherence tomography images for the analysis of human atherosclerotic plaques

EuroIntervention 2012;8:98-108

Published in Volume 8 Number 1, May 2012

Embolic protection devices during TAVI – the “proof of the pudding”

EuroIntervention 2012;8:25-29 publish online ahead of print March 2012

Published in Volume 8 Number 1, May 2012

Pockets full of good news in the Age of Reason

EuroIntervention 2012;8:13

Published in Volume 8 Number 1, May 2012

In vivo visualisation by three-dimensional optical coherence tomography of stress crazing of a bioresorbable vascular scaffold implanted for treatment of human coronary stenosis

EuroIntervention 2012;7:1461-1463 publish online ahead of print September 2011

Published in Volume 7 Number 12, April 2012

Long-term outcome after statin treatment in routine clinical practice: results from a prospective PCI cohort study

EuroIntervention 2012;7:1420-1427

Published in Volume 7 Number 12, April 2012

Smoke without fire?

EuroIntervention 2012;7:1365

Published in Volume 7 Number 12, April 2012

Advances in two-dimensional quantitative coronary angiographic assessment of bifurcation lesions: improved small lumen diameter detection and automatic reference vessel diameter derivation

EuroIntervention 2012;7:1326-1335

Published in Volume 7 Number 11, March 2012

Reflections on questions in valve and structural heart

EuroIntervention 2012;7:1245-1247

Published in Volume 7 Number 11, March 2012

In vivo characterisation of bioresorbable vascular scaffold strut interfaces using optical coherence tomography with Gaussian line spread function analysis

EuroIntervention 2012;7:1227-1235 publish online ahead of print December 2011

Published in Volume 7 Number 10, February 2012

High-speed intracoronary optical frequency domain imaging: implications for three-dimensional reconstruction and quantitative analysis

EuroIntervention 2012;7:1216-1226

Published in Volume 7 Number 10, February 2012

Unravelling the complexities of the coronary bifurcation: is this raising a few eyebrows?

EuroIntervention 2012;7:1133-1141

Published in Volume 7 Number 10, February 2012

A shrinking world?

EuroIntervention 2012;7:1127

Published in Volume 7 Number 10, February 2012

How should I treat an iatrogenic aortic dissection as a complication of complex PCI?

EuroIntervention 2012;7:1111-1117

Published in Volume 7 Number 9, January 2012

Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial

EuroIntervention 2012;7:1060-1061 publish onlinea ahead of print September 2011

Published in Volume 7 Number 9, January 2012

How to remain focussed in a globalised world

EuroIntervention 2012;7:1009-1010

Published in Volume 7 Number 9, January 2012

Rationale and design of the EXAMINATION trial: a randomised comparison between everolimus-eluting stents and cobalt-chromium bare-metal stents in ST-elevation myocardial infarction

EuroIntervention 2011;7:977-984 publish online ahead of print November 2011

Published in Volume 7 Number 8, December 2011

Three-year clinical event rates in different age groups after contemporary percutaneous coronary intervention

EuroIntervention 2011;7:969-976 publish online ahead of print March 2011

Published in Volume 7 Number 8, December 2011

A tradition of learning and international exchange in interventional cardiology: a speciality with a “whole-world” embrace

EuroIntervention 2011;7:889-891

Published in Volume 7 Number 8, December 2011

Cardiovascular risk profile of patients included in stent trials; a pooled analysis of individual patient data from randomised clinical trials: insights from 33 prospective stent trials in Europe

EuroIntervention 2011;7:859-871

Published in Volume 7 Number 7, November 2011

The three year follow-up of the randomised “all-comers” trial of a biodegradable polymer biolimus-eluting stent versus permanent polymer sirolimus-eluting stent (LEADERS)

EuroIntervention 2011;7:789-795 publish online ahead of print October 2011

Published in Volume 7 Number 7, November 2011

First clinical evaluation of a luminal self-expanding shield in patients with intermediate coronary lesions

EuroIntervention 2011;7:780-788

Published in Volume 7 Number 7, November 2011

Where have all the pioneers gone?

EuroIntervention 2011;7:769-771

Published in Volume 7 Number 7, November 2011

Tools & Techniques: Risk stratification and diagnostic tools in left main stem intervention

EuroIntervention 2011;7:747-753

Published in Volume 7 Number 6, October 2011

Percutaneous coronary intervention versus bypass surgery for left main coronary artery disease: a meta-analysis of randomised trials

EuroIntervention 2011;7:738-746 publish online ahead of print August 2011

Published in Volume 7 Number 6, October 2011

Paclitaxel-coated balloon in combination with bare metal stent for treatment of de novo coronary lesions: an optical coherence tomography first-in-human randomised trial, balloon first vs. stent first

EuroIntervention 2011;7:711-722 publish online ahead of print June 2011

Published in Volume 7 Number 6, October 2011

Angiographic outcomes following stenting or coronary artery bypass surgery of the left main coronary artery: fifteen-month outcomes from the synergy between PCI with TAXUS express and cardiac surgery left main angiographic substudy (SYNTAX-LE MANS)

EuroIntervention 2011;7:670-679 publish online ahead of print July 2011

Published in Volume 7 Number 6, October 2011

Leading the dialogue

EuroIntervention 2011;7:649-651

Published in Volume 7 Number 6, October 2011

How should I treat impaired systolic function and clinical deterioration after surgery of type A aortic dissection?

EuroIntervention 2011;7:638-646

Published in Volume 7 Number 5, September 2011

A novel dedicated 3-dimensional quantitative coronary analysis methodology for bifurcation lesions

EuroIntervention 2011;7:629-635 publish online ahead of print January 2011

Published in Volume 7 Number 5, September 2011

Implantation of the biodegradable polymer biolimus-eluting stent in patients with high SYNTAX score is associated with decreased cardiac mortality compared to a permanent polymer sirolimus-eluting stent: two year follow-up results from the “all-comers” LEADERS trial

EuroIntervention 2011;7:605-613 publish online ahead of print June 2011

Published in Volume 7 Number 5, September 2011

Six-month clinical and angiographic results of the STENTYS® self-apposing stent in bifurcation lesions

EuroIntervention 2011;7:580-587

Published in Volume 7 Number 5, September 2011

Aortic annulus dimensions and leaflet calcification from contrast MSCT predict the need for balloon post-dilatation after TAVI with the Medtronic CoreValve prosthesis

EuroIntervention 2011;7:564-572 publish online ahead of print June 2011

Published in Volume 7 Number 5, September 2011

Fast tracking to the future with EEP

EuroIntervention 2011;7:531

Published in Volume 7 Number 5, September 2011

CRosser As First choice for crossing Totally occluded coronary arteries (CRAFT Registry): focus on conventional angiography and computed tomography angiography predictors of success

EuroIntervention 2011;7:480-486 published online ahead of print June 2011

Published in Volume 7 Number 4, August 2011

Assessment of the safety and performance of the STENTYS self-expanding coronary stent in acute myocardial infarction: results from the APPOSITION I study

EuroIntervention 2011;7:1-15

Published in Volume 7 Number 4, August 2011

The “seasons” of cardiology

EuroIntervention 2011;7:411-413

Published in Volume 7 Number 4, August 2011

Optical coherence tomography (OCT) of overlapping bioresorbable scaffolds: from benchwork to clinical application

EuroIntervention 2011;7:386-399 published online ahead of print January 2011

Published in Volume 7 Number 3, July 2011

Virtual bench testing of new generation coronary stents: why would we want to publish this paper?

EuroIntervention 2011;7:295-296

Published in Volume 7 Number 3, July 2011

“Finally, we may be all wrong... but only time will tell if we were right”

EuroIntervention 2011;7:293

Published in Volume 7 Number 3, July 2011

In memoriam

EuroIntervention 2011;7:291

Published in Volume 7 Number 3, July 2011

Healing of a coronary artery dissection detected by intravascular ultrasound and optical coherence tomography

EuroIntervention 2011;7:288-289

Published in Volume 7 Number 2, June 2011

Moxy® drug-coated balloon: a novel device for the treatment of coronary and peripheral vascular disease

EuroIntervention 2011;7:274-277 published online ahead of print May 2011

Published in Volume 7 Number 2, June 2011

Looking back into the future: desirudin in acute coronary syndromes and coronary stenting

EuroIntervention 2011;7:263-269

Published in Volume 7 Number 2, June 2011

Prevalence and prognostic implications of baseline anaemia in patients undergoing transcatheter aortic valve implantation

EuroIntervention 2011;7:184-191 published online ahead of print May 2011

Published in Volume 7 Number 2, June 2011

EuroPCR 2011: the ongoing challenge of initiatives and innovations

EuroIntervention 2011;7:173-175

Published in Volume 7 Number 2, June 2011

Procedural valve dislodgment with the Medtronic CoreValve: incidence, predictors and how to overcome

Published in Volume 7 Supplement M, May 2011

Determinants of paravalvular aortic regurgitation after transcatheter aortic valve implantation

Published in Volume 7 Supplement M, May 2011

Left ventricular mass regression one year after TAVI

Published in Volume 7 Supplement M, May 2011

Health-related quality-of-life shows sustained improvement with transcatheter aortic valve

Published in Volume 7 Supplement M, May 2011

Timing and potential mechanisms of new conduction abnormalities during the implantation of the Medtronic CoreValve system in patients with aortic stenosis

Published in Volume 7 Supplement M, May 2011

Frequency of conduction abnormalities after TAVI with the Medtronic-CoreValve and the effect on left ventricular ejection fraction

Published in Volume 7 Supplement M, May 2011

The use of 3-dimensional reconstruction of optical frequency domain imaging to improve our understanding of conventional PCI: the potential for clinical application

Published in Volume 7 Supplement M, May 2011

Quantitative multi-modality imaging analysis of a fully bioresorbable scaffold: a head-to-head comparison between quantitative coronary angiography, intravascular ultrasound and optical coherence tomography

Published in Volume 7 Supplement M, May 2011

A six-month analysis of quantitative echogenicity of the second generation everolimus-eluting bioresorbable vascular scaffold in relationship with baseline greyscale intravascular ultrasound morphology of the scaffolded plaque

Published in Volume 7 Supplement M, May 2011

Tissue coverage and neointimal hyperplasia of overlap vs. non-overlap segments in DES 9-13 months after implantation: in vivo-assessment with optical coherence tomography

Published in Volume 7 Supplement M, May 2011

Paclitaxel-coated balloon in combination with bare metal stent for treatment of de novo coronary lesions: an optical coherence tomography first-in-man randomised trial balloon first vs. stent first

Published in Volume 7 Supplement M, May 2011

Complex coronary bifurcation lesions treated with the novel polymer-free dedicated bifurcation paclitaxel-eluting stent (Nile pax): clinical and angiographic clinical results of the prospective, multicentre bipax clinical trial

Published in Volume 7 Supplement M, May 2011

Well developed collateral circulation is associated with better vascular function distal to recanalised coronary chronic total occlusions

Published in Volume 7 Supplement M, May 2011

Capture of circulatory endothelial progenitor cells and accelerated re-endothelialisation of a bioengineered stent in human ex vivo shunt and rabbit denudation model

Published in Volume 7 Supplement M, May 2011

Long-term tissue coverage of a bioresorbable polylactide polymer-coated Biolimus-eluting stent: comparative sequential assessment with optical coherence tomography till complete resorption of the polymer

Published in Volume 7 Supplement M, May 2011

Tissue coverage of a hydrophilic polymer-coated Zotarolimus-eluting stent vs. a fluoropolymer-coated Everolimus-eluting stent at 13-month follow-up: an optical coherence tomography substudy from the RESOLUTE all-comers trial

Published in Volume 7 Supplement M, May 2011

Vascular healing response five years after implantation of first generation DES: the SIRTAX LATE optical coherence study

Published in Volume 7 Supplement M, May 2011

Conformability of the Nevo; Sirolimus-eluting coronary stent system in comparison with the Xience; Everolimus-eluting coronary stent system: results from a bench top study and an angiographic assessment from the Nevo II clinical trial

Published in Volume 7 Supplement M, May 2011

First-in-man, multicentre assessment of the novel Acrobat Svelt balloon-expandable stent-on-a-wire system

Published in Volume 7 Supplement M, May 2011

Plaque sealing and passivation with a mechanical self-expanding low outward force nitinol VShield device for the treatment of intravascular ultrasound and optical coherence tomography-derived thin cap fibroatheromas (TCFAS) in native coronary arteries

Published in Volume 7 Supplement M, May 2011

Spatial distribution and temporal evolution of scattering centers by optical coherence tomography in the poly(L-lactide) backbone of a bioresorbable vascular scaffold

Published in Volume 7 Supplement M, May 2011

Intracoronary delivery of allogeneic mesenchymal precursor cells directly after acute myocardial infarction improves cardiac function and myocardial perfusion and decreases left ventricular remodeling in sheep

Published in Volume 7 Supplement M, May 2011

Pooled analysis of the Resolute programme clinical safety results

Published in Volume 7 Supplement M, May 2011

Treatment with the Resolute Zotarolimus-eluting stent in subjects with diabetes mellitus: pooled analysis from the Resolute clinical programme

Published in Volume 7 Supplement M, May 2011

Incidence of stent thrombosis in two large registries in Europe and Japan: a patient level data analysis from the Bern-Rotterdam and J-CYPHER registries

Published in Volume 7 Supplement M, May 2011

Impact of stent thrombosis on clinical outcomes among patients undergoing PCI with newer generation DES

Published in Volume 7 Supplement M, May 2011

Thrombectomy vs. no thrombectomy before stenting in acute myocardial infarction: an optical coherence tomographic evaluation

Published in Volume 7 Supplement M, May 2011

Transcatheter indirect mitral annuloplasty with the PTMA system: a technical report

EuroIntervention 2011;7:164-169

Published in Volume 7 Number 1, May 2011

How should I treat acute valve regurgitation?

EuroIntervention 2011;7:151-159

Published in Volume 7 Number 1, May 2011

Impact factors: scientific and career assessment by numbers

EuroIntervention 2011;7:143-147

Published in Volume 7 Number 1, May 2011

High shear stress induces a strain increase in human coronary plaques over a 6-month period

EuroIntervention 2011;7:121-127

Published in Volume 7 Number 1, May 2011

Predictors of death or myocardial infarction, ischaemic-driven revascularisation, and major adverse cardiovascular events following everolimus-eluting or paclitaxel-eluting stent deployment: pooled analysis from the SPIRIT II, III, IV and COMPARE trials

EuroIntervention 2011;7:74-83

Published in Volume 7 Number 1, May 2011

Effect of paclitaxel elution from reservoirs with bioabsorbable polymer compared to a bare metal stent for the elective percutaneous treatment of de novo coronary stenosis: the EUROSTAR-II randomised clinical trial

EuroIntervention 2011;7:64-73

Published in Volume 7 Number 1, May 2011

The rites of spring

EuroIntervention 2011;7:15-17

Published in Volume 7 Number 1, May 2011

Clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound regression/progression studies

EuroIntervention 2011;6:1123-1130

Published in Volume 6 Number 9, April 2011

Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study

EuroIntervention 2011;6:1110-1116

Published in Volume 6 Number 9, April 2011

Retrospective image-based gating of intracoronary optical coherence tomography: implications for quantitative analysis

EuroIntervention 2011;6:1098-1103

Published in Volume 6 Number 9, April 2011

Five-year outcomes of percutaneous coronary intervention compared to bypass surgery in patients with multivessel disease involving the proximal left anterior descending artery: an ARTS-II sub-study

EuroIntervention 2011;6:1060-1067 - DOI10.4244/EIJV6I9A185

Published in Volume 6 Number 9, April 2011

First-in-man evaluation of intravascular optical frequency domain imaging (OFDI) of Terumo: a comparison with intravascular ultrasound and quantitative coronary angiography

EuroIntervention 2011;6:1037-1045

Published in Volume 6 Number 9, April 2011

To be equal before them: natural tragedies, gender and a shrinking world

EuroIntervention 2011;6:1025-1027

Published in Volume 6 Number 9, April 2011

New technologies in percutaneous coronary interventions: drug-coated balloons

EuroIntervention 2011;7:K7

Published in Volume 7 Supplement K, May 2011

In vivo findings of tissue characteristics using iMap™ IVUS and Virtual Histology™ IVUS

EuroIntervention 2011;6:1017-1019

Published in Volume 6 Number 8, March 2011

Intravascular ultrasound radiofrequency analysis after optimal coronary stenting with initial quantitative coronary angiography guidance: an ATHEROREMO sub-study

EuroIntervention 2010;6:977-984 - DOI10.4244/EIJV6I6A169

Published in Volume 6 Number 8, March 2011

Magnetic navigation system assisted stenting of coronary bifurcation lesions

EuroIntervention 2011;6:970-976

Published in Volume 6 Number 8, March 2011

Risk-benefit trade-offs in revascularisation choices

EuroIntervention 2011;6:936-941

Published in Volume 6 Number 8, March 2011

The outcome of bifurcation lesion stenting using a biolimuseluting stent with a bio-degradable polymer compared to a sirolimus-eluting stent with a durable polymer

EuroIntervention 2011;6:928-935

Published in Volume 6 Number 8, March 2011

A guide to interpreting and assessing the performance of prediction models

EuroIntervention 2011;6:909-912

Published in Volume 6 Number 8, March 2011

Changing seasons; measuring clinical options and practice

EuroIntervention 2011;6:907

Published in Volume 6 Number 8, March 2011

Influence of age on the clinical outcomes of coronary revascularisation for the treatment of patients with multivessel de novo coronary artery lesions: sirolimus-eluting stent vs. coronary artery bypass surgery and bare metal stent, insight from the multicentre randomised Arterial Revascularisation Therapy Study Part I (ARTS-I) and Part II (ARTS-II)

EuroIntervention 2010;6:838-845 - DOI10.4244/EIJV6I6A144

Published in Volume 6 Number 7, February 2011

Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial

EuroIntervention 2010;6:805-812 - DOI10.4244/EIJV6I6A139

Published in Volume 6 Number 7, February 2011

In the shortest month

EuroIntervention 2011;6:787

Published in Volume 6 Number 7, February 2011

Essentials of quantitative angiography for bifurcation lesions

EuroIntervention Supplement (2010) Vol. 6 (Supplement J) J36-J43

Published in Volume 6 Supplement J, December 2010

The EuroIntervention bifurcation supplement

EuroIntervention Supplement (2010) Vol. 6 (Supplement J) J7

Published in Volume 6 Supplement J, December 2010

The feasibility and safety of applying the Magnetic Navigation System to manage chronically occluded vessels: a single centre experience

EuroIntervention 2011;6:711-716 published online ahead of print November 2010

Published in Volume 6 Number 6, January 2011

Late outcome after intracoronary beta radiation brachytherapy: a matched-propensity controlled ten-year follow-up study

EuroIntervention 2011;6:695-702

Published in Volume 6 Number 6, January 2011

Eight-year clinical outcome after radioactive stent implantation: a treatment failure without irreversible long-term clinical sequelae

EuroIntervention 2011;6:681-686

Published in Volume 6 Number 6, January 2011

Transcatheter valves and interventional cardiology

EuroIntervention 2011;6:673-677

Published in Volume 6 Number 6, January 2011

Every month, and everywhere, EuroIntervention

EuroIntervention 2011;6:667

Published in Volume 6 Number 6, January 2011

PCR London Valves: focus on TAVI

EuroIntervention 2010;6:547

Published in Volume 6 Number 5, November 2010

The use of MSCT for the evaluation of the aortic root before transcutaneous aortic valve implantation: the Rotterdam approach

EuroIntervention 2010;6:505-511 published online ahead of print May 2010

Published in Volume 6 Number 4, September 2010

Persistent conduction abnormalities and requirements for pacemaking six months after transcatheter aortic valve implantation

EuroIntervention 2010;6:475-484 published online ahead of print August 2010

Published in Volume 6 Number 4, September 2010

Three-year results of clinical follow-up after a bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB trial

EuroIntervention 2010;6:447-453 published online ahead of print June 2010

Published in Volume 6 Number 4, September 2010

ETHICA Award 2010: Antonio Colombo

EuroIntervention 2010;6:431

Published in Volume 6 Number 4, September 2010

Encouraging exchange: launching of the Surgeons' Corner in EuroIntervention

EuroIntervention 2010;6:429

Published in Volume 6 Number 4, September 2010

How should I treat a staggering TAVI procedure?

EuroIntervention 2010;6:418-423

Published in Volume 6 Number 3, August 2010

The coronary Stent-On-A-Wire (SOAW)

EuroIntervention 2010;6:413-417

Published in Volume 6 Number 3, August 2010

A quantitative coronary angiography-matched comparison between a prospective randomised multicentre cutting balloon angioplasty and bare metal stent trial (REDUCE III) and the Rapamycin-Eluting Stent Evaluation At Rotterdam Cardiology Hospital (RESEARCH) study

EuroIntervention 2010;6:400-406

Published in Volume 6 Number 3, August 2010

Reproducibility of coronary Fourier domain optical coherence tomography: quantitative analysis of in vivo stented coronary arteries using three different software packages

EuroIntervention 2010;6:371-379

Published in Volume 6 Number 3, August 2010

A comparison of the distribution of necrotic core in bifurcation and non-bifurcation coronary lesions: an in vivo assessment using intravascular ultrasound radiofrequency data analysis

EuroIntervention 2010;6:321-327

Published in Volume 6 Number 3, August 2010

Key word: collaboration

EuroIntervention 2010;6:293

Published in Volume 6 Number 3, August 2010

The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer

EuroIntervention 2010;6:233-239

Published in Volume 6 Number 2, June 2010

PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study

EuroIntervention 2010;6:220-226

Published in Volume 6 Number 2, June 2010

A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II study

EuroIntervention 2010;6:195-205

Published in Volume 6 Number 2, June 2010

Could this be Europe's last chance for a viable journal of Interventional Cardiovascular Imaging?

EuroIntervention 2010;6:173

Published in Volume 6 Number 2, June 2010

Optical coherence tomography in patients with acute coronary syndrome

EuroIntervention Supplement (2010) Vol. 6 (Supplement G) G154-G160

Published in Volume 6 Supplement G, May 2010

Computed tomography as a tool for percutaneous coronary intervention of chronic total occlusions

EuroIntervention Supplement (2010) Vol. 6 (Supplement G) G123-G131

Published in Volume 6 Supplement G, May 2010

Cardiac CT: necessary for precise sizing for transcatheter aortic implantation

EuroIntervention Supplement (2010) Vol. 6 (Supplement G) G6-G13

Published in Volume 6 Supplement G, May 2010

How should I treat a tortuous calcified right coronary artery?

EuroIntervention 2010;6:161-167

Published in Volume 6 Number 1, May 2010

EuroIntervention, a bright light

EuroIntervention 2010;6:1-00

Published in Volume 6 Number 1, May 2010

Stable durability and effectiveness at 2 years with CoreValve transcatheter aortic valve

Published in Volume 6 Supplement H, May 2010

In-hospital complications after transcatheter aortic valve implantation revisited according to the Valvular Academic Research Consortium definitions

Published in Volume 6 Supplement H, May 2010

The coronary stent-on-a-wire (SOAW)

Published in Volume 6 Supplement H, May 2010

Two-year results after the unrestricted use of everolimus-eluting and paclitaxel-eluting stents: a propensity-matching analysis from the XSEARCH and T-SEARCH registries

Published in Volume 6 Supplement H, May 2010

Assessment of the aortic annulus by multislice computed tomography, contrast aortography and trans-thoracic echocardiography in patients referred for transcatheter aortic valve implantation

Published in Volume 6 Supplement H, May 2010

Repeat left main revascularisation in patients with de novo left main disease treated with percutaneous coronary intervention using Taxus Express2 paclitaxel-eluting stent in the SYNTAX trial

Published in Volume 6 Supplement H, May 2010

Correlation of angiographic findings with clinical events following stenting or coronary artery bypass surgery of the left main coronary artery: 24-month outcomes from the synergy between percutaneous coronary intervention with Taxus express and cardiac surgery left main angiographic sub-study (SYNTAX-LE MANS)

Published in Volume 6 Supplement H, May 2010

Coronary bifurcation lesions treated with the novel Nile PAX polymer-free dedicated bifurcation paclitaxel-eluting stent. Preliminary results from the prospective, multicenter BIPAX clinical trial

Published in Volume 6 Supplement H, May 2010

Conformability of bioresorbable Everolimus-eluting scaffolds as compared to metal platform stents

Published in Volume 6 Supplement H, May 2010

Malapposed struts in drug-eluting stents entail higher risk of incomplete tissue coverage at 9- to 13-month follow-up compared to well-apposed struts: in vivo demonstration with optical coherence tomography

Published in Volume 6 Supplement H, May 2010

Implications of floating struts at side branches in the tissue coverage of drug-eluting stents at 9- to 13-months follow-up: in vivo assessment with optical coherence tomography

Published in Volume 6 Supplement H, May 2010

Nobori 1 - long term results: 3 years phase 1 & 2 and 4 years phase 1

Published in Volume 6 Supplement H, May 2010

Multicentre, prospective, randomised, single blind, consecutive enrollment evaluation of the Elixir Novolimus-eluting coronary stent system with durable polymer compared to the Endeavor Zotarolimus-eluting coronary stent system: 12-month clinical results and 9-month angiographic and IVUS results - the Excella II study

Published in Volume 6 Supplement H, May 2010

ABSORB cohort B trial: 6-month imaging (IVUS, IVUS-VH, OCT) results of the evaluation of the bioresorbable everolimus-eluting coronary vascular scaffold (BVS) in the treatment of patients with de novo native coronary artery lesions

Published in Volume 6 Supplement H, May 2010

Introduction to the scientific abstract presentations at EuroPCR 2010

Published in Volume 6 Supplement H, May 2010

Short- and long-term health related quality-of-life and anginal status of the Arterial Revascularisation Therapies Study part II, ARTS-II; sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease

EuroIntervention 2010;5:962-967

Published in Volume 5 Number 8, April 2010

In vivo evaluation of stent strut distribution patterns in the bioabsorbable everolimus-eluting device: an OCT ad hoc analysis of the revision 1.0 and revision 1.1 stent design in the ABSORB clinical trial

EuroIntervention 2010;5:932-938 - DOI10.4244/EIJV5I8A157

Published in Volume 5 Number 8, April 2010

Like multitudes: using the power of numbers to illuminate

EuroIntervention 2010;5:877

Published in Volume 5 Number 8, April 2010

Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity

EuroIntervention 2010;5:871-874

Published in Volume 5 Number 7, February 2010

How should I treat an unusual referral for heart transplantation?

EuroIntervention 2010;5:861-865

Published in Volume 5 Number 7, February 2010

A pooled gender based analysis comparing the XIENCE V® everolimus-eluting stent and the TAXUS paclitaxel-eluting stent in male and female patients with coronary artery disease, results of the SPIRIT II and SPIRIT III studies: two-year analysis

EuroIntervention 2010;5:788-794

Published in Volume 5 Number 7, February 2010

AsiaPCR/ SingLIVE, a new evolution, among others for the PCR community

EuroIntervention 2010;5:759-761

Published in Volume 5 Number 7, February 2010

First use in patients of a combined near infra-red spectroscopy and intra-vascular ultrasound catheter to identify composition and structure of coronary plaque

EuroIntervention 2010;5:755-756

Published in Volume 5 Number 6, January 2010

A clinical protocol for analysis of the structural integrity of the Medtronic CoreValve System® frame and its application in patients with 1-year minimum follow-up

EuroIntervention 2010;5:680-686

Published in Volume 5 Number 6, January 2010

Vascular complications with transcatheter aortic valve implantation using the 18 Fr Medtronic CoreValve System®: the Rotterdam experience

EuroIntervention 2010;5:673-679

Published in Volume 5 Number 6, January 2010

The times, they are a-changing... constantly!

EuroIntervention 2010;5:639-641

Published in Volume 5 Number 6, January 2010

Ten-year follow-up of the IGAKI-TAMAI stent.

EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F109-F111

Published in Volume 5 Supplement F, December 2009

Everolimus-eluting bioabsorbable stent – Abbot Vascular programme

EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F98-F102

Published in Volume 5 Supplement F, December 2009

Vascular Restoration Therapy: the fourth revolution in interventional cardiology and the ultimate “Rosy” prophecy

EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F7-F8

Published in Volume 5 Supplement F, December 2009

How should I treat a complex Post-CABG patient?

EuroIntervention 2009;5:627-632

Published in Volume 5 Number 5, November 2009

A comparison of patient characteristics and 30-day mortality outcomes after transcatheter aortic valve implantation and surgical aortic valve replacement for the treatment of aortic stenosis: a two-centre study

EuroIntervention 2009;5:580-588

Published in Volume 5 Number 5, November 2009

Compositional volumetry of non-calcified coronary plaques by multislice computed tomography: an ex vivo feasibility study

EuroIntervention 2009;5:558-564

Published in Volume 5 Number 5, November 2009

Transferability of data between different drug-eluting stents

EuroIntervention 2009;5:527-531

Published in Volume 5 Number 5, November 2009

Reflections on that "City by the Bay"; a smaller world for better patient care

EuroIntervention 2009;5:521

Published in Volume 5 Number 5, November 2009

The use of drug-eluting stents in ST-elevation myocardial infarction

EuroIntervention 2009;5:494-500

Published in Volume 5 Number 4, September 2009

Assisted circulation using the Tandemheart®, percutaneous transseptal left ventricular assist device, during percutaneous aortic valve implantation: the Rotterdam experience

EuroIntervention 2009;5:465-469 - DOI10.4244/EIJV5I4A74

Published in Volume 5 Number 4, September 2009

Planting strong roots for the future

EuroIntervention 2009;5:403

Published in Volume 5 Number 4, September 2009

Biolimus-eluting biodegradable polymer versus sirolimus-eluting permanent polymer stent performance in long lesions: results from the LEADERS multicentre trial substudy

EuroIntervention 2009;5:310-317 - DOI10.4244/EIJV5I3A49

Published in Volume 5 Number 3, August 2009

Our European present

EuroIntervention 2009;5:283

Published in Volume 5 Number 3, August 2009

Percutaneous coronary intervention with oral sirolimus and bare metal stents has comparable safety and efficacy to treatment with drug eluting stents, but with significant cost saving: long-term follow-up results from the randomised, controlled ORAR III (Oral Rapamycin in ARgentina) study Alfredo E.

EuroIntervention 2009;5:255-264

Published in Volume 5 Number 2, June 2009

Reproducibility of quantitative optical coherence tomography for stent analysis

EuroIntervention 2009;5:224-232

Published in Volume 5 Number 2, June 2009

Long-term outcome after the V stenting technique in de novo bifurcation lesions using drug-eluting stents

EuroIntervention 2009;5:197-205

Published in Volume 5 Number 2, June 2009

Three-year clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularisation Therapies Study, part II (ARTS II)

EuroIntervention 2009;5:190:196

Published in Volume 5 Number 2, June 2009

Tissue characterisation using intravascular radiofrequency data analysis: recommendations for acquisition, analysis, interpretation and reporting

EuroIntervention 2009;5:177-189

Published in Volume 5 Number 2, June 2009

Transcatheter Aortic Valve Implantation. Where are we?

EuroIntervention 2009;5:169-171

Published in Volume 5 Number 2, June 2009

EuroIntervention and EuroPCR 2009. A truly "Grand Cru"

EuroIntervention 2009;5:167

Published in Volume 5 Number 2, June 2009

Effect of clopidogrel discontinuation at 1 year after drug eluting stent placement on inflammatory and platelet activation markers: DECADES (Discontinuation Effect of Clopidogrel After Drug Eluting Stent). A multicenter, open-label study

Published in Volume 5 Supplement E, May 2009

The outcome of bifurcation lesion stenting using a biolimus eluting stent with a biodegradable polymer compared to a sirolimus eluting stent with a durable polymer

Published in Volume 5 Supplement E, May 2009

Five-year clinical outcomes of the arterial revascularisation therapies (ARTS-II) study of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions

Published in Volume 5 Supplement E, May 2009

Lowering the dose of sirolimus, released from a non-polymeric hydroxy-apatite coated coronary stent, reduces signs of delayed healing

Published in Volume 5 Supplement E, May 2009

Impact of gender on three-year outcome following percutaneous coronary intervention using bare-metal and drug-eluting stent in de-novo coronary artery disease – Insights from the RESEARCH and T-SEARCH Registries

Published in Volume 5 Supplement E, May 2009

Early and late graft occlusion and stent thrombosis: analysis from the SYNTAX Trial

Published in Volume 5 Supplement E, May 2009

A comparison of patient characteristics and 30-day mortality outcomes after transcatheter aortic valve implantation and surgical aortic valve replacement for the treatment of severe aortic stenosis: a two-center propensity score analysis study

Published in Volume 5 Supplement E, May 2009

Economic evaluation of drug-eluting stents vs. bypass surgery for patients with 3-vessel and left main coronary artery disease: 1-year results from the SYNTAX trial

Published in Volume 5 Supplement E, May 2009

Endothelial progenitor cell (EPC) capture in stented porcine coronary arteries increases endothelialisation but does not affect intimal thickening

Published in Volume 5 Supplement E, May 2009

A multicentre evaluation of the safety of intracoronary optical coherence tomography

EuroIntervention 2009;5:90-95

Published in Volume 5 Number 1, May 2009

Assessment of the SYNTAX score in the Syntax study

EuroIntervention 2009;5:50-56 - DOI10.4244/EIJV5I1A09

Published in Volume 5 Number 1, May 2009

Counting the score: the SYNTAX Score and coronary risk

EuroIntervention 2009;5:33-35

Published in Volume 5 Number 1, May 2009

Clinical endpoints in transcatheter aortic valve implantation: a call to ARC for standardised definitions

EuroIntervention 2009;5:29-31

Published in Volume 5 Number 1, May 2009

The rites of spring

EuroIntervention 2009;5:13

Published in Volume 5 Number 1, May 2009

Optical coherence tomography (OCT) in secondary revascularisation: stent and graft assessment

EuroIntervention Supplement (2009) Vol. 5 (Supplement D) D93-D100

Published in Volume 5 Supplement D, May 2009

Meditations on secondary revascularisation in the aftermath of the SYNTAX trial

EuroIntervention Supplement (2009) Vol. 5 (Supplement D) D14-D20

Published in Volume 5 Supplement D, May 2009

Foreword

EuroIntervention Supplement (2009) Vol. 5 (Supplement D) D5

Published in Volume 5 Supplement D, May 2009

Computed Tomography in Total coronary Occlusions (CTTO Registry): radiation exposure and predictors of successful percutaneous intervention

EuroIntervention 2009;4:607-616 - DOI10.4244/EIJV4I5A102

Published in Volume 4 Number 5, March 2009

Interventional treatment in diabetics in the era of drug-eluting stents and compliance to the ESC guidelines: lessons learned from the Euro Heart Survey Programme

EuroIntervention 2009;4:578-587 - DOI10.4244/EIJV4I5A98

Published in Volume 4 Number 5, March 2009

First-in-man (FIM) study of the Stentys™ bifurcation stent – 30 days results

EuroIntervention 2009;4:566-571 - DOI10.4244/EIJV4I5A96

Published in Volume 4 Number 5, March 2009

Keynote Address – EuroPCR 2008, Barcelona, May 14th, 2008

EuroIntervention 2009;4:558-565 - DOI10.4244/EIJV4I5A95

Published in Volume 4 Number 5, March 2009

A rich and varied offering

EuroInterv.2009;4:549

Published in Volume 4 Number 5, March 2009

Magnetically navigated percutaneous coronary intervention in distal and/or complex lesions may improve procedural outcome and material consumption

EuroInterv.2009;4:517-523

Published in Volume 4 Number 4, January 2009

Integration of 3D reconstruction in the SELection criteria for Excessive Crossing Times for Magnetically Supported Percutaneous Coronary Intervention. SELECT-MP

EuroInterv.2009;4:509-516

Published in Volume 4 Number 4, January 2009

Effect of gender differences on early and mid-term clinical outcome after percutaneous or surgical coronary revascularisation in patients with multivessel coronary artery disease: Insights from ARTS I and ARTS II

EuroInterv.2009;4:492-501

Published in Volume 4 Number 4, January 2009

The relative safety and efficacy of bare-metal and drug-eluting stents in low and high-risk patient subsets. An epidemiological analysis of three sequential cohorts of consecutive all comers (n=6129)

EuroInterv.2009;4:464-474

Published in Volume 4 Number 4, January 2009

Assessment of the absorption process following bioabsorbable everolimus-eluting stent implantation: temporal changes in strain values and tissue composition using intravascular ultrasound radiofrequency data analysis. A substudy of the ABSORB clinical trial.

EuroInterv.2009;4:443-448

Published in Volume 4 Number 4, January 2009

Meeting report. ESC Forum on Drug Eluting Stents, European Heart House, Nice, 27-28 September 2007

EuroInterv.2009;4:427-436

Published in Volume 4 Number 4, January 2009

PUBMED/MEDLINE indexing

EuroInterv.2009;4:413

Published in Volume 4 Number 4, January 2009

A primer on the immune system in the pathogenesis and treatment of atherosclerosis

EuroInterv.2008;4:378-390

Published in Volume 4 Number 3, November 2008

Early echocardiographic evaluation following percutaneous implantation with the self-expanding CoreValve ReValving System aortic valve bioprosthesis

EuroInterv.2008;4:351-357

Published in Volume 4 Number 3, November 2008

The TandemHeart®, percutaneous transseptal left ventricular assist device: a safeguard in high-risk percutaneous coronary interventions. The six-year Rotterdam experience

EuroInterv.2008;4:331-337

Published in Volume 4 Number 3, November 2008

Four-year safety and efficacy of the unrestricted use of sirolimus- and paclitaxel-eluting stents in coronary artery bypass grafts

EuroIntervention 2008;4:311-317 - DOI10.4244/EIJV4I3A57

Published in Volume 4 Number 3, November 2008

Together, we can truly insure the future

EuroInterv.2008;4:301

Published in Volume 4 Number 3, November 2008

Jacques Puel memorial

EuroInterv.2008;4:299

Published in Volume 4 Number 3, November 2008

Identifying stent thrombosis, a critical appraisal of the Academic Research Consortium (ARC) consensus definitions: a lighthouse and as a toe in the water

EuroIntervention Supplement (2008) Vol. 4 (Supplement C) C39-C44

Published in Volume 4 Supplement C, August 2008

The influence of shear stress on in-stent restenosis and thrombosis

EuroIntervention Supplement (2008) Vol. 4 (Supplement C) C27-C32

Published in Volume 4 Supplement C, August 2008

How should I treat a patient with severe and symptomatic aortic stenosis who is rejected for surgical and transfemoral valve replacement and in whom a transapical implantation was aborted?

EuroInterv.2008;4:292-296

Published in Volume 4 Number 2, August 2008

Quantitative multi-modality imaging analysis of a bioabsorbable poly-L-lactic acid stent design in the acute phase: a comparison between 2- and 3D-QCA, QCU and QMSCT-CA

EuroIntervention 2008;4:285-291 - DOI10.4244/EIJV4I2A49

Published in Volume 4 Number 2, August 2008

Elective implantation of sirolimus-eluting stents for bifurcated and non-bifurcated unprotected left main coronary artery lesions: clinical outcomes at one year

EuroIntervention 2008;4:262-270 - DOI10.4244/EIJV4I2A46

Published in Volume 4 Number 2, August 2008

Population characteristics, treatment assignment and survival of patients with aortic stenosis referred for percutaneous valve replacement

EuroInterv.2008;4:250-255

Published in Volume 4 Number 2, August 2008

Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve ReValving System: results from the multicentre, expanded evaluation registry 1-year following CE mark approval

EuroIntervention 2008;4:242-249 - DOI10.4244/EIJV4I2A43

Published in Volume 4 Number 2, August 2008

Self-promotional, or taking the lead?

EuroInterv.2008;4:167

Published in Volume 4 Number 2, August 2008

Proof-of-concept trial to evaluate haemoglobin based oxygen therapeutics in elective percutaneous coronary revascularisation. Rationale, protocol design and haemodynamic results

EuroIntervention 2008;4:99-107 - DOI10.4244/EIJV4I1A17

Published in Volume 4 Number 1, May 2008

European experience with the retrograde approach for the recanalisation of coronary artery chronic total occlusions.

EuroIntervention 2008;4:84-92 - DOI10.4244/EIJV4I1A15

Published in Volume 4 Number 1, May 2008

Diabetic patients treated for unprotected left main coronary artery disease with drug eluting stents: a 3-year clinical outcome study. The Diabetes and Drug Eluting stent for LeFT main registry (D-DELFT)

EuroInterv.2008;4:77-83

Published in Volume 4 Number 1, May 2008

Today Europe, tomorrow the world!

EuroInterv.2008;4:15

Published in Volume 4 Number 1, May 2008

Myocardial infarction in a patient with sickle cell trait. Treatment dilemmas and imaging findings at follow-up

EuroInterv.2008;3:627-634

Published in Volume 3 Number 5, March 2008

Haemodynamic effects, safety, and tolerability of haemoglobin-based oxygen carrier-201 in patients undergoing PCI for CAD

EuroIntervention 2008;3:600-609 - DOI10.4244/EIJV3I5A108

Published in Volume 3 Number 5, March 2008

Differentiated analysis of an everolimus-eluting stent and a paclitaxel-eluting stent among higher risk subgroups for restenosis: results from the SPIRIT II trial

EuroIntervention 2008;3:566-573 - DOI10.4244/EIJV3I5A102

Published in Volume 3 Number 5, March 2008

A novel dedicated quantitative coronary analysis methodology for bifurcation lesions

EuroIntervention 2008;3:553-557 - DOI10.4244/EIJV3I5A100

Published in Volume 3 Number 5, March 2008

Tryton I, First-In-Man (FIM) study: six month clinical and angiographic outcome, analysis with new quantitative coronary angiography dedicated for bifurcation lesions

EuroInterv.2008;3:546-552

Published in Volume 3 Number 5, March 2008

The challenge of innovation: lost opportunities and new and uncharted futures

EuroInterv.2008;3:533

Published in Volume 3 Number 5, March 2008

Short- and long- term health related quality-of-life and anginal status after randomisation to coronary stenting versus bypass surgery for the treatment of multivessel disease: results of the Arterial Revascularisation Therapy Study (ARTS)

EuroIntervention 2007;3:506-511 - DOI10.4244/EIJV3I4A89

Published in Volume 3 Number 4, January 2008

Three-year follow-up of the ARTS-II# – Sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease

EuroInterv.2008;3:450-459

Published in Volume 3 Number 4, January 2008

An insight into the current use of drug eluting stents in acute and elective percutaneous coronary interventions in Europe: a report on the EuroPCI Survey

EuroInterv.2008;3:429-441

Published in Volume 3 Number 4, January 2008

Taking the "measure" of a profession

EuroInterv.2008;3:421

Published in Volume 3 Number 4, January 2008

A pooled safety analysis of data comparing paclitaxel-eluting stents with bare-metal stents

EuroIntervention 2007;3:392-399 - DOI10.4244/EIJV3I3A70

Published in Volume 3 Number 3, November 2007

Accelerated vascular repair following percutaneous coronary intervention by capture of endothelial progenitor cells promotes regression of neointimal growth at long term follow-up: final results of the Healing II trial using an endothelial progenitor cell capturing stent (Genous R stent)™

EuroInterv.2007;3:350-358

Published in Volume 3 Number 3, November 2007

One year clinical follow-up of the XIENCE V Everolimus-eluting stent system in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II study

EuroInterv.2007;3:315-320

Published in Volume 3 Number 3, November 2007

The SCAAR registry or the Swedish yo-yo

EuroIntervention 2007;3:297-300 - DOI10.4244/EIJV3I3A54

Published in Volume 3 Number 3, November 2007

At the dawning of interventional cardiology: Andreas Gruentzig, 30 years after
15 September 1977-15 September 2007

EuroInterv.2007;3:293

Published in Volume 3 Number 3, November 2007

Ultrasonic and pathological evidence of a neo-intimal plaque rupture in patients with bare metal stents

EuroInterv.2007;3:290-291

Published in Volume 3 Number 2, August 2007

Two-year results of a durable polymer everolimus-eluting stent in de novo coronary artery stenosis (The SPIRIT FIRST Trial)

EuroInterv.2007;3:206-212

Published in Volume 3 Number 2, August 2007

Contemporary treatment of patients with chronic total occlusion: critical appraisal of different state-of-the-art techniques and devices

EuroIntervention 2007;3:188-196 - DOI10.4244/EIJV3I2A34

Published in Volume 3 Number 2, August 2007

Medicine in Europe: proudly forging our own unique identity

EuroInterv.2007;3:167

Published in Volume 3 Number 2, August 2007

Rationale and interim analysis data from the SEISMIC study

EuroIntervention Supplements (2007) 2 (Supplement B) B84-B88

Published in Volume 2 Supplement B, April 2007

Clinical experience with autologous myoblast transplantation

EuroIntervention Supplements (2007) 2 (Supplement B) B71-B78

Published in Volume 2 Supplement B, April 2007

Magnetically supported procedures and cardiac regeneration

EuroIntervention Supplements (2007) 2 (Supplement B) B42-B46

Published in Volume 2 Supplement B, April 2007

Adipose derived stem cells: new kids on the block

EuroIntervention 2007;2:B26-B32 - DOI10.4244/EIJV2IBA05

Published in Volume 2 Supplement B, April 2007

MAHOROBA™: Tacrolimus eluting coronary stent

EuroInterv.2007;3:149-153

Published in Volume 3 Number 1, May 2007

First experience with remote left ventricular mapping and transendocardial cell injection with a novel integrated magnetic navigation-guided electromechanical mapping system

EuroInterv.2007;3:142-148

Published in Volume 3 Number 1, May 2007

In vivo validation of a novel three-dimensional quantitative coronary angiography system (CardiOp-B™): comparison with a conventional two-dimensional system (CAAS II™) and with special reference to optical coherence tomography

EuroIntervention 2007;3:100-108 - DOI10.4244/EIJV3I1A16

Published in Volume 3 Number 1, May 2007

The European cobalt STent with Antiproliferative for Restenosis trial (EuroSTAR): 12 month results

EuroInterv.2007;3:82-88

Published in Volume 3 Number 1, May 2007

Circulating endothelial progenitor cells predict angiographic and intravascular ultrasound outcome following percutaneous coronary interventions in the HEALING-II trial: evaluation of an endothelial progenitor cell capturing stent

EuroIntervention 2007;3:67-75 - DOI10.4244/EIJV3I1A11

Published in Volume 3 Number 1, May 2007

Tryton I, First-In-Man (FIM) Study: acute and 30 day outcome.

EuroIntervention 2007;3:54-59 - DOI10.4244/EIJV3I1A09

Published in Volume 3 Number 1, May 2007

European perspective in the recanalisation of Chronic Total Occlusions (CTO): consensus document from the EuroCTO Club

EuroInterv.2007;3:30-43

Published in Volume 3 Number 1, May 2007

A space for dialogue and innovation, for protocols and practicalities

EuroInterv.2007;3:15

Published in Volume 3 Number 1, May 2007

Left ventricular angiogram in a patient with noncompaction cardiomyopathy

EuroInterv.2007;2:533-534

Published in Volume 2 Number 4, February 2007

True percutaneous implantation of the CoreValve aortic valve prosthesis by the combined use of ultrasound guided vascular access, Prostar® XL and the TandemHeart®

EuroIntervention 2007;2:500-505 - DOI10.4244/EIJV2I4A88

Published in Volume 2 Number 4, February 2007

Revisiting the incidence and temporal distribution of cardiac and sudden death in patients undergoing elective intervention for unprotected left main coronary artery stenosis in the drug eluting stent era
A pooled analysis on 340 patients treated at three European referral centres

EuroInterv.2007;2:435-443

Published in Volume 2 Number 4, February 2007

Randomised comparison of Nobori™, biolimus A9-eluting coronary stent with a Taxus®, paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the Nobori 1 trial

EuroIntervention 2007;2:426-434 - DOI10.4244/EIJV2I4A78

Published in Volume 2 Number 4, February 2007

FDA panel, 7 and 8 December 2006 - The impact on our practice and research

EuroInterv.2007;2:405-407

Published in Volume 2 Number 4, February 2007

Biodegradable drug eluting stents: invasive and non-invasive imaging

EuroInterv.2006;2:403

Published in Volume 2 Number 3, November 2006

Virtual histology and remodelling index allow in vivo identification of allegedly high-risk coronary plaques in patients with acute coronary syndromes: a three vessel intravascular ultrasound radiofrequency data analysis

EuroInterv.2006;2:338-344

Published in Volume 2 Number 3, November 2006

Two-year clinical follow-up of the unrestricted use of the paclitaxel-eluting stent compared to the sirolimus-eluting stent as part of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry

EuroIntervention 2006;2:330-337 - DOI10.4244/EIJV2I3A59

Published in Volume 2 Number 3, November 2006

Biodegradable-polymer-based, paclitaxel-eluting Infinnium™ stent: 9-Month clinical and angiographic follow-up results from the SIMPLE II prospective multi-centre registry study

EuroIntervention 2006;2:310-317 - DOI10.4244/EIJV2I3A56

Published in Volume 2 Number 3, November 2006

A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent:

EuroIntervention 2006;2:286-294 - DOI10.4244/EIJV2I3A53

Published in Volume 2 Number 3, November 2006

Editorial

EuroIntervention 2006;2:273-275 - DOI10.4244/EIJV2I3A48

Published in Volume 2 Number 3, November 2006

Shear stress is associated with markers of plaque vulnerability and MMP-9 activity

EuroIntervention 2006;2:250-256 - DOI10.4244/EIJV2I2A42

Published in Volume 2 Number 2, August 2006

Clinical and angiographic follow-up after overlapping implantation of polytetrafluoroethylene covered stents with drug eluting stents

EuroInterv.2006;2:218-223

Published in Volume 2 Number 2, August 2006

Sex differences and their impact on clinical outcome after percutaneous or surgical revascularisation: a report from the Arterial Revascularisation Therapies Study (ARTS)

EuroIntervention 2006;2:175-180 - DOI10.4244/EIJV2I2A30

Published in Volume 2 Number 2, August 2006

The future of European percutaneous cardiovascular interventions

EuroInterv.2006;2:143-145

Published in Volume 2 Number 2, August 2006

Left ventricular assist device support during percutaneous aortic valve implantation under intracardiac echocardiography guidance

EuroIntervention Supplements (2006) 1 (Supplement A) A68-A71

Published in Volume 1 Supplement A, April 2006

Preface: Percutaneous valve interventions

EuroIntervention Supplements (2006) 1 (Supplement A) A2

Published in Volume 1 Supplement A, April 2006

IVUS beyond the horizon

EuroIntervention 2006;2:132-142 - DOI10.4244/EIJV2I1A23

Published in Volume 2 Number 1, May 2006

Use of Impella Recover® LP 2.5 left ventricular assist device during high-risk percutaneous coronary interventions; clinical, haemodynamic and biochemical findings

EuroIntervention 2006;2:91-100 - DOI10.4244/EIJV2I1A15

Published in Volume 2 Number 1, May 2006

First-In-Man application of a miniature self-contained intracoronary magnetic resonance probe.
A multi-centre safety and feasibility trial

EuroInterv.2006;2:77-83

Published in Volume 2 Number 1, May 2006

One-year results of coronary revascularization in diabetic patients with multivessel coronary artery disease.

EuroIntervention 2006;2:69-76 - DOI10.4244/EIJV2I1A12

Published in Volume 2 Number 1, May 2006

Integrated analysis of medically treated diabetic patients in the TAXUS® program: benefits across stent platforms, paclitaxel release formulations, and diabetic treatments

EuroIntervention 2006;2:61-68 - DOI10.4244/EIJV2I1A11

Published in Volume 2 Number 1, May 2006

Physicians, the medical device industry and the data; a healthy relationship?

EuroInterv.2006;2:19-22

Published in Volume 2 Number 1, May 2006

Editorial

EuroInterv.2006;2:13

Published in Volume 2 Number 1, May 2006

Paclitaxel-eluting stent restenosis shows three-layer appearance by optical coherence tomography

EuroInterv.2006;1:484

Published in Volume 1 Number 4, February 2006

Reliable angiographic evaluation by 64-slice computed tomography after trifurcation stenting of the left main coronary artery

EuroInterv.2006;1:482-483

Published in Volume 1 Number 4, February 2006

Percutaneous aortic valve replacement in a patient who could not undergo surgical treatment.

EuroInterv.2006;1:475-479

Published in Volume 1 Number 4, February 2006

Intracardiac echocardiography during interventional procedures

EuroIntervention 2006;1:454-464 - DOI10.4244/EIJV1I4A76

Published in Volume 1 Number 4, February 2006

Myocardial repair by percutaneous cell transplantation of autologous skeletal myoblast as a stand alone procedure in post myocardial infarction chronic heart failure patients

EuroInterv.2006;1:417-424

Published in Volume 1 Number 4, February 2006

Introduction and thoughts on the fourth issue of EuroIntervention

EuroInterv.2006;1:369

Published in Volume 1 Number 4, February 2006

Detection of a necrotic core-rich, highly deformable plaque in an angiographically non-diseased proximal LAD

EuroInterv.2005;1:367

Published in Volume 1 Number 3, November 2005

Feasibility and safety of guidewire navigation using a magnetic navigation system in coronary artery stenoses

EuroIntervention 2005;1:329-335 - DOI10.4244/EIJV1I3A54

Published in Volume 1 Number 3, November 2005

Magnetic navigation in a coronary phantom: experimental results

EuroIntervention 2005;1:321-328 - DOI10.4244/EIJV1I3A53

Published in Volume 1 Number 3, November 2005

First-in-man prospective evaluation of temporal changes in coronary plaque composition by in vivo intravascular ultrasound radiofrequency data analysis: an Integrated Biomarker and Imaging Study (IBIS) substudy

EuroIntervention 2005;1:282-288 - DOI10.4244/EIJV1I3A47

Published in Volume 1 Number 3, November 2005

One-year results of a durable polymer everolimus-eluting stent in de novo coronary narrowings
(The SPIRIT FIRST Trial)

EuroInterv.2005;1:266-272

Published in Volume 1 Number 3, November 2005

Serial assessment of tissue growth inside and outside the stent after implantation of drug-eluting stent in clinical trials. - Does delayed neointimal growth exist?

EuroInterv.2005;1:253-255

Published in Volume 1 Number 3, November 2005

Assessment of stent dimensions with a novel intracoronary balloon-based system: comparative study versus intravascular ultrasound and quantitative coronary angiography. The CAMUS - Coronary Angioplasty Metricath vs. UltraSound Trial

EuroIntervention 2005;1:244-251 - DOI10.4244/EIJV1I2A39

Published in Volume 1 Number 2, August 2005

The effect of variable release kinetics on Paclitaxel efficacy from a drug eluting stent in a porcine model

EuroIntervention 2005;1:228-235 - DOI10.4244/EIJV1I2A37

Published in Volume 1 Number 2, August 2005

The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease

EuroInterv.2005;2:219-227

Published in Volume 1 Number 2, August 2005

Drug-eluting stent implantation for chronic total occlusions: comparison between the Sirolimus- and Paclitaxel-eluting stent

EuroInterv.2005;2:193-197

Published in Volume 1 Number 2, August 2005

Drug-eluting stent-supported percutaneous coronary intervention in high risk patients refused cardiac surgery

EuroInterv.2005;2:181-185

Published in Volume 1 Number 2, August 2005

One-year clinical outcome of various doses and pharmacokinetic release formulations of paclitaxel eluted from an erodable polymer - Insight in the Paclitaxel In-Stent Controlled Elution Study (PISCES)

EuroIntervention 2005;1:165-172 - DOI10.4244/EIJV1I2A27

Published in Volume 1 Number 2, August 2005

Arterial Revascularisation Therapies Study Part II - Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions

EuroIntervention 2005;1:147-156 - DOI10.4244/EIJV1I2A25

Published in Volume 1 Number 2, August 2005

Introduction and thoughts on the second issue of EuroIntervention

EuroInterv.2005;2:121

Published in Volume 1 Number 2, August 2005

Intracoronary thermography: heat generation, transfer and detection

EuroInterv.2005;1:105-114

Published in Volume 1 Number 1, May 2005

A randomized comparison of a durable polymer

EuroIntervention 2005;1:58-65 - DOI10.4244/EIJV1I1A07

Published in Volume 1 Number 1, May 2005

The history of EuroPCR... and why a new journal?

EuroInterv.2005;1:4-5

Published in Volume 1 Number 1, May 2005